FWIA
BIO icon

Fort Washington Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fort Washington Investment Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,467
Closed -$7.85M – 491
2020
Q4 		$7.85M Sell
13,467
-2,570
-16% -$1.46M 0.08% 204
2020
Q3 		$8.27M Sell
16,037
-2,748
-15% -$1.39M 0.09% 160
2020
Q2 		$8.48M Sell
18,785
-103,905
-85% -$45.9M 0.1% 177
2020
Q1 		$43M Sell
122,690
-23,991
-16% -$8.82M 0.58% 46
2019
Q4 		$54.3M Sell
146,681
-2,012
-1% -$709K 0.58% 48
2019
Q3 		$49.5M Sell
148,693
-7,342
-5% -$2.4M 0.55% 48
2019
Q2 		$48.8M Sell
156,035
-19,123
-11% -$5.73M 0.54% 47
2019
Q1 		$53.5M Sell
175,158
-25,544
-13% -$6.89M 0.6% 45
2018
Q4 		$46.6M Sell
200,702
-3,565
-2% -$957K 0.57% 47
2018
Q3 		$63.9M Sell
204,267
-85,906
-30% -$26.7M 0.63% 39
2018
Q2 		$83.7M Sell
290,173
-22,639
-7% -$6.25M 0.85% 32
2018
Q1 		$78.2M Sell
312,812
-13,173
-4% -$3.35M 0.81% 35
2017
Q4 		$77.8M Sell
325,985
-35,057
-10% -$8.5M 0.77% 35
2017
Q3 		$80.2M Sell
361,042
-21,130
-6% -$4.75M 1.24% 28
2017
Q2 		$86.5M Sell
382,172
-50,804
-12% -$11.1M 1.36% 24
2017
Q1 		$86.3M Sell
432,976
-2,180
-0.5% -$420K 1.38% 26
2016
Q4 		$79.3M Buy
435,156
+30,144
+7% +$5.14M 1.32% 30
2016
Q3 		$66.3M Sell
405,012
-203
-0.1% -$30.8K 1.19% 28
2016
Q2 		$58M Buy
405,215
+223
+0.1% +$31.8K 1.08% 34
2016
Q1 		$55.4M Buy
404,992
+8,616
+2% +$1.13M 1.07% 33
2015
Q4 		$55M Buy
396,376
+11,465
+3% +$1.59M 1.11% 30
2015
Q3 		$51.7M Buy
384,911
+14,082
+4% +$2.03M 1.07% 31
2015
Q2 		$55.9M Buy
370,829
+47,858
+15% +$6.85M 1.05% 30
2015
Q1 		$43.7M Buy
322,971
+2,081
+0.6% +$258K 0.87% 36
2014
Q4 		$38.7M Buy
320,890
+28,071
+10% +$3.23M 0.78% 38
2014
Q3 		$33.2M Buy
292,819
+23,920
+9% +$2.83M 0.69% 44
2014
Q2 		$32.2M Buy
268,899
+61,797
+30% +$7.55M 0.62% 47
2014
Q1 		$26.5M Hold
207,102
– – 0.57% 49
2013
Q4 		$25.6M Buy
207,102
+8,177
+4% +$996K 0.58% 47
2013
Q3 		$23.4M Buy
+198,925
New +$23.5M 0.56% 46

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Fort Washington Investment Advisors's BIO Position: Q1 2021 in Review

Fort Washington Investment Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2021, closing a stake of 13,467 shares — an estimated $7.85M sold.

Fort Washington Investment Advisors first reported a position in BIO in Q3 2013 and held it in 30 quarters. The position peaked at $86.5M in Q2 2017. 491 funds tracked by Wall St. Rank hold BIO as of Q1 2021.

  • Fort Washington Investment Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2021 after selling out during the quarter.
  • Fort Washington Investment Advisors sold 13,467 Bio-Rad Laboratories Class A shares in Q1 2021, an estimated $7.85M.
  • Fort Washington Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2013 and held it in 30 quarters.
  • Fort Washington Investment Advisors's Bio-Rad Laboratories Class A position peaked at $86.5M in Q2 2017.
  • 491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2021.

Based on Fort Washington Investment Advisors's 13F filing for Q1 2021, filed 5 May 2021.